An Important Check-Up On Vanda Pharmaceuticals Inc (NASDAQ: VNDA)

Vanda Pharmaceuticals Inc (VNDA) concluded trading on Thursday at a closing price of $4.07, with 2.6 million shares of worth about $10.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.50% during that period and on Thursday the price saw a gain of about 11.81%. Currently the company’s common shares owned by public are about 57.53M shares, out of which, 55.58M shares are available for trading.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 27 times over the past 12 months. They bought 358,743 shares in 11 of the transactions. In 16 selling transactions, insiders dumped 147,282 shares.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

However, the stock later moved at a day high price of 4.4100, or with a gain of 11.81%. Stock saw a price change of 9.12% in past 5 days and over the past one month there was a price change of -2.40%. Year-to-date (YTD), VNDA shares are showing a performance of -3.55% which decreased to -46.16% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.30 but also hit the highest price of $8.15 during that period. The average intraday trading volume for Vanda Pharmaceuticals Inc shares is 974.46K. The stock is currently trading 9.20% above its 20-day simple moving average (SMA20), while that difference is up 5.08% for SMA50 and it goes to -19.36% lower than SMA200.

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) currently have 57.53M outstanding shares and institutions hold larger chunk of about 90.86% of that.

The stock has a current market capitalization of $234.15M and its 3Y-monthly beta is at 0.71. PE ratio of stock for trailing 12 months is 93.14, while it has posted earnings per share of $0.04 in the same period. Its PEG reads 2.58 and has Quick Ratio of 4.92 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VNDA, volatility over the week remained 8.10% while standing at 5.54% over the month.

Analysts are in expectations that Vanda Pharmaceuticals Inc (VNDA) stock would likely to be making an EPS of -$0.08 in the current quarter, while forecast for next quarter EPS is -$0.11 and it is -$0.94 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.08 which is -$0.08 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.12 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -75.00% while it is estimated to decrease by -4900.00% in next year. EPS is likely to grow at an annualized rate of 36.10% for next 5-years, compared to annual growth of -37.98% made by the stock over the past 5-years.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on February 25, 2022 offering a Hold rating for the stock and assigned a target price range of between $24 and $12 to it.

Most Popular

Related Posts